Shakespeare Wealth Management’s iShares iBonds Dec 2022 Term Corporate ETF IBDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-16,702
Closed -$422K 73
2019
Q4
$422K Buy
16,702
+38
+0.2% +$961 0.23% 51
2019
Q3
$422K Buy
16,664
+119
+0.7% +$3K 0.24% 49
2019
Q2
$417K Buy
+16,545
New +$413K 0.27% 45

Other funds holding IBDN

Shakespeare Wealth Management's IBDN Position: Q1 2020 in Review

Shakespeare Wealth Management sold out of iShares iBonds Dec 2022 Term Corporate ETF (IBDN) in Q1 2020, closing a stake of 16,702 shares — an estimated $422K sold.

Shakespeare Wealth Management first reported a position in IBDN in Q2 2019 and held it in 3 quarters. The position peaked at $422K in Q4 2019. 172 funds tracked by Wall St. Rank hold IBDN as of Q1 2020.

  • Shakespeare Wealth Management reported no remaining iShares iBonds Dec 2022 Term Corporate ETF position as of Q1 2020 after selling out during the quarter.
  • Shakespeare Wealth Management sold 16,702 iShares iBonds Dec 2022 Term Corporate ETF shares in Q1 2020, an estimated $422K.
  • Shakespeare Wealth Management first reported a position in iShares iBonds Dec 2022 Term Corporate ETF in Q2 2019 and held it in 3 quarters.
  • Shakespeare Wealth Management's iShares iBonds Dec 2022 Term Corporate ETF position peaked at $422K in Q4 2019.
  • 172 funds tracked by Wall St. Rank held iShares iBonds Dec 2022 Term Corporate ETF as of Q1 2020.

Based on Shakespeare Wealth Management's 13F filing for Q1 2020, filed 1 Apr 2020.